sj-pptx-2-tam-10.1177_17588359211042812 – Supplemental material for Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

Han, Hye Sook; Kim, Bum Jun; Jee, Hee-Jung; Ryu, Min-Hee; Park, Se Hoon; Rha, Sun Young; Kim, Jong Gwang; Bae, Woo Kyun; Lee, Keun-Wook; Oh, Do-Youn; Kim, In-Ho; Sym, Sun Jin; Oh, So Yeon; Kim, Hyeong Su; Byun, Ji-Hye; Kim, Dong Sook; Suh, Young Ju; An, Hyonggin; Zang, Dae Young

doi:10.25384/SAGE.16641232.v1

sj-pptx-2-tam-10.1177_17588359211042812.pptx (71.58 kB)

sj-pptx-2-tam-10.1177_17588359211042812 – Supplemental material for Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16)

presentation

posted on 2021-09-19, 12:06 authored by Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang

Supplemental material, sj-pptx-2-tam-10.1177_17588359211042812 for Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) by Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An and Dae Young Zang in Therapeutic Advances in Medical Oncology